PPIs as possible risk factor for copper deficiency myelopathy

J Neurol Sci. 2015 Feb 15;349(1-2):258-9. doi: 10.1016/j.jns.2015.01.009. Epub 2015 Jan 12.

Authors

Domenico Plantone¹, Rosaria Renna², Guido Primiano³, Arif Shukralla⁴, Tatiana Koudriavtseva²

Affiliations

¹ Multiple Sclerosis Center, Unit of Neurology, Regina Elena National Cancer Institute, IFO, Rome, Italy. Electronic address: [email protected].
² Multiple Sclerosis Center, Unit of Neurology, Regina Elena National Cancer Institute, IFO, Rome, Italy.
³ Institute of Neurology, Department of Geriatrics, Neurosciences and Orthopedics, Catholic University, Rome, Italy.
⁴ Department of Neurosciences, Royal Preston Hospital, Preston, UK.

PMID: 25598493
DOI: 10.1016/j.jns.2015.01.009

No abstract available

Keywords: Copper deficiency myelopathy; Proton pump inhibitors; Spinal cord.

Publication types

Letter
Comment

MeSH terms

Ataxia / complications*
Copper / blood*
Female
Humans
Male
Spinal Cord Diseases / blood*
Spinal Cord Diseases / complications*
Vitamin B 12 / blood*
Zinc / blood*

Substances

Copper
Zinc
Vitamin B 12